Currently, there are 766.10M common shares owned by the public and among those 759.55M shares have been available to trade.
The company’s stock has a 5-day price change of 0.10% and 8.17% over the past three months. AGNC shares are trading 2.55% year to date (YTD), with the 12-month market performance up to 0.20% higher. It has a 12-month low price of $6.81 and touched a high of $10.57 over the same period. AGNC has an average intraday trading volume of 12.94 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -0.50%, 2.06%, and 6.68% respectively.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Institutional ownership of AGNC Investment Corp (NASDAQ: AGNC) shares accounts for 38.48% of the company’s 766.10M shares outstanding.
It has a market capitalization of $7.71B and a beta (3y monthly) value of 1.45. The stock’s trailing 12-month PE ratio is 27.77, while the earnings-per-share (ttm) stands at $0.36. The company has a debt-to-equity ratio at 8.12. Price movements for the stock have been influenced by the stock’s volatility, which stands at 1.37% over the week and 1.84% over the month.
Earnings per share for the fiscal year are expected to decrease by -18.77%, and -6.74% over the next financial year. EPS should grow at an annualized rate of -1.81% over the next five years, compared to -24.53% over the past 5-year period.
Janney coverage for the AGNC Investment Corp (AGNC) stock in a research note released on June 06, 2024 offered a Buy rating with a price target of $10.50. Compass Point was of a view on February 20, 2024 that the stock is Buy, while UBS gave the stock Neutral rating on December 06, 2023, issuing a price target of $9. Barclays on their part issued Equal Weight rating on November 15, 2023.
